Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Prostate Cancer

Overdiagnosis: when finding cancer can do more harm than good

With new cancer detection technology on the horizon, ranging from blood tests to wristbands, understanding overdiagnosis is a huge challenge.

Why a one-off PSA test for prostate cancer is doing men more harm than good

Our new research shows that a one-off PSA test doesn't save lives from prostate cancer.

One-off PSA screening for prostate cancer does not save lives

Inviting men with no symptoms to a one-off PSA test for prostate cancer does not save lives according to results from the largest ever prostate cancer trial.

Apalutamide delays spread of certain prostate cancers in trial

An experimental hormone therapy delays the spread of prostate cancer that has stopped responding to standard treatment, according to new clinical trial results.

Big data analysis predicts risk of radiotherapy side effects

Analysing big data to predict men’s risk of side effects could help personalise radiotherapy treatment for prostate cancer.

Low testosterone levels linked to reduced risk of prostate cancer

Men with unusually low amounts of testosterone in their blood are around 20% less likely to develop prostate cancer.

Availability of robotic prostate cancer surgery could be a bigger draw for patients than quality of hospital

Prostate cancer patients may base choice of hospital for surgery on availability of new technology, rather than hospital quality information, according to study

News digest – repurposed drugs, HIV, bisphosphonates and… a prostate cancer ‘cure’?

From this week’s cancer news we look at how HIV research could offer clues about lung cancer and bust headlines about a radiotherapy ‘cure’ for prostate cancer.

Pelvis-targeting radiotherapy safe for prostate cancer patients

A form of radiotherapy targeting the pelvis is safe for men with advanced localised prostate cancer, according to a new study.

Two treatments for advanced prostate cancer bring equal benefits

Unpublished results from the Cancer Research UK-funded STAMPEDE trial show that two different treatments improve survival in men with advanced prostate cancer.